KALA BIO (KALA)

Last close As at 14/01/2026

USD0.63

0.02 (3.94%)

Market capitalisation

USD15m

KALA BIO is a clinical-stage biotechnology company advancing its proprietary mesenchymal stem cell secretome (MSC-S) platform towards rare eye diseases, with lead candidate KPI-012 targeting ocular surface diseases.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Todd Bazemore

    CEO

  • Mary Reumuth

    CFO